Akèy › Anplwayè › Patient Square Capital LP
Patient Square Capital LP: Salè H-1B ak pajon
Patient Square Capital LP depoze 10 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 10. Medyèn salè yo ofri a: $230,000.
Èske Patient Square Capital LP pajone visa H-1B?
Patient Square Capital LP depoze 10 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 1, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Vice President | 1 | $375,000 |
| Senior Research Associate | 1 | $250,000 |
| Deal Professional Associate | 1 | $212,500 |
| Private Equity Associate | 1 | $165,000 |
| Deal Professional Vice President | 1 | $275,000 |
| Associate Director | 1 | $230,000 |
| Vice President, Finance and Operations | 1 | $245,000 |
| Director | 1 | $230,000 |
| Biotech Investment Analyst | 1 | $210,000 |
| Cloud Infrastructure Engineer - Azure, Security & Networking | 1 | $210,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 2 | $312,500 |
| FY2025 | 2 | $188,750 |
| FY2026 | 6 | $230,000 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Financial and Investment Analysts4
- Management Analysts2
- Survey Researchers1
- Economists1
- Financial Managers1
- Computer Systems Engineers/Architects1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Cloud Infrastructure Engineer - Azure, Security & Networking | $210,000 Nivo IV | Menlo Park, CA | Jun 1, 2026 | Jun 15, 2026 | Certifye |
| Vice President, Finance and Operations | $245,000 Nivo III | Menlo Park, CA | Apr 16, 2026 | Oct 1, 2026 | Certifye |
| Biotech Investment Analyst | $210,000 Nivo IV | Menlo Park, CA | Apr 16, 2026 | Oct 1, 2026 | Certifye |
| Director | $230,000 Nivo IV | New York, NY | Apr 16, 2026 | Oct 1, 2026 | Certifye |
| Associate Director | $230,000 Nivo IV | Menlo Park, CA | Apr 15, 2026 | Oct 1, 2026 | Certifye |
| Deal Professional Vice President | $275,000 Nivo IV | Menlo Park, CA | Mar 23, 2026 | Apr 1, 2026 | Certifye |
| Deal Professional Associate | $212,500 Nivo IV | Menlo Park, CA | May 23, 2025 | Jul 21, 2025 | Certifye |
| Private Equity Associate | $165,000 Nivo III | Menlo Park, CA | May 12, 2025 | Oct 1, 2025 | Certifye |
| Senior Research Associate | $250,000 Nivo IV | 100, CA | May 15, 2023 | May 29, 2023 | Certifye |
| Vice President | $375,000 Nivo IV | Menlo Park, CA | Jan 4, 2023 | Apr 4, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).